We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

334 hedge funds and large institutions have $7.13B invested in United Therapeutics in 2014 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 93 increasing their positions, 147 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

5% more funds holding

Funds holding: 319 → 334 (+15)

5% more capital invested

Capital invested by funds: $6.8B → $7.13B (+$336M)

4% more call options, than puts

Call options by funds: $39.2M | Put options by funds: $37.8M

28% less funds holding in top 10

Funds holding in top 10: 18 → 13 (-5)

37% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 147

Holders
334
Holders Change
+15
Holders Change %
+4.7%
% of All Funds
8.91%
Holding in Top 10
13
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-27.78%
% of All Funds
0.35%
New
54
Increased
93
Reduced
147
Closed
36
Calls
$39.2M
Puts
$37.8M
Net Calls
+$1.37M
Net Calls Change
+$239M

Top Buyers

1
SCM
Scopia Capital Management
New York
+$41.6M
2
AQR Capital Management
AQR Capital Management
Connecticut
+$41.6M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$32.3M
4
IAM
Iridian Asset Management
Connecticut
+$30.4M
5
First Trust Advisors
First Trust Advisors
Illinois
+$27.1M

Top Sellers

1
HCM
Herndon Capital Management
Georgia
-$145M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$87.6M
3
WG
Winton Group
United Kingdom
-$48.4M
4
AL
AJO LP
Pennsylvania
-$39.3M
5
Los Angeles Capital Management
Los Angeles Capital Management
California
-$32.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
TD Asset Management
151
TD Asset Management
Ontario, Canada
$3.35M +$374K +2,900 +13%
N
152
Nuveen
North Carolina
$3.13M – – –
Jacobs Levy Equity Management
153
Jacobs Levy Equity Management
New Jersey
$3.12M -$520K -4,035 -14%
MSA
154
Mason Street Advisors
Wisconsin
$3.08M -$28.6K -222 -0.9%
VOYA Investment Management
155
VOYA Investment Management
Georgia
$2.97M -$1.42M -11,026 -32%
SOMRS
156
State of Michigan Retirement System
Michigan
$2.93M +$25.8K +200 +0.9%
UBS Group
157
UBS Group
Switzerland
$2.89M +$2.88M +22,327 New
CAM
158
ClariVest Asset Management
California
$2.74M -$18.6K -144 -0.7%
SEI Investments
159
SEI Investments
Pennsylvania
$2.72M +$2.7M +20,927 New
GC
160
Globeflex Capital
California
$2.64M -$3.15M -24,409 -54%
American Century Companies
161
American Century Companies
Missouri
$2.62M -$21.7M -168,096 -89%
EA
162
Emerald Advisers
Pennsylvania
$2.62M +$2.6M +20,209 New
GS
163
GAM Systematic
United Kingdom
$2.6M +$2.58M +20,044 New
AP
164
AHL Partners
United Kingdom
$2.59M +$2.58M +19,986 New
LAM
165
Lingohr Asset Management
Germany
$2.49M -$1.22M -9,500 -25%
OPPM
166
Opus Point Partners Management
New York
$2.47M +$2.46M +19,054 New
CM
167
Capital Management
Virginia
$2.46M +$1.81M +14,055 +283%
AIP
168
Ameritas Investment Partners
Nebraska
$2.21M – – –
Nisa Investment Advisors
169
Nisa Investment Advisors
Missouri
$2.12M – – –
BA
170
Boston Advisors
Massachusetts
$2.07M +$789K +6,120 +62%
Ohio Public Employees Retirement System (OPERS)
171
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.06M +$423K +3,281 +26%
MCM
172
Matarin Capital Management
New York
$2.05M -$840K -6,516 -29%
MERSOM
173
Municipal Employees' Retirement System of Michigan
Michigan
$1.99M +$366K +2,840 +23%
WCBA
174
Weaver C. Barksdale & Associates
Tennessee
$1.98M +$1.97M +15,264 +36,343%
PAM
175
Panagora Asset Management
Massachusetts
$1.97M -$1.15M -8,904 -37%
5 6
7
8 9

UTHR Hedge Fund Activity: Q4 2014 in Review

334 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2014, worth a combined $7.13B — up 4.9% from $6.8B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new UTHR positions and 36 closed out — a net gain of 18 holders — while 93 added to existing stakes and 147 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $41.6M. The largest seller was Herndon Capital Management, cutting an estimated $145M.

  • 334 institutional investors held United Therapeutics (UTHR) as of Q4 2014, up from 319 in Q3 2014.
  • Funds reported $7.13B of United Therapeutics stock for Q4 2014, up 4.9% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q4 2014 and 36 closed out, a net change of +18 holders.
  • The largest United Therapeutics buyer in Q4 2014 was Scopia Capital Management, an estimated $41.6M added.
  • The largest United Therapeutics seller in Q4 2014 was Herndon Capital Management, an estimated $145M sold.

Based on aggregated 13F filings for Q4 2014.